Lazard Asset Management LLC Charles River Laboratories International, Inc. Transaction History

Lazard Asset Management LLC

  • $58.2 Billion
  • Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 4,246 shares of CRL stock, worth $751,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,246
Previous 10,757 60.53%
Holding current value
$751,244
Previous $1.99 Million 67.81%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$150.52 - $190.14 $980,035 - $1.24 Million
-6,511 Reduced 60.53%
4,246 $639,000
Q4 2024

Feb 14, 2025
BUY
$178.58 - $220.69 $570,384 - $704,883
3,194 Added 42.23%
10,757 $1.99 Million
Q3 2024

Nov 14, 2024
SELL
$187.96 - $245.29 $5.17 Million - $6.74 Million
-27,487 Reduced 78.42%
7,563 $1.49 Million
Q2 2024

Aug 14, 2024
SELL
$206.39 - $268.73 $6.23 Million - $8.11 Million
-30,184 Reduced 46.27%
35,050 $7.24 Million
Q1 2024

May 14, 2024
BUY
$203.52 - $273.43 $2.22 Million - $2.99 Million
10,928 Added 20.12%
65,234 $17.7 Million
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $373,295 - $541,927
2,269 Added 4.36%
54,306 $12.8 Million
Q3 2023

Nov 14, 2023
BUY
$194.44 - $217.61 $6.6 Million - $7.38 Million
33,918 Added 187.2%
52,037 $10.2 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $524,492 - $600,263
2,855 Added 18.7%
18,119 $3.81 Million
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $95,945 - $129,960
500 Added 3.39%
15,264 $3.08 Million
Q4 2022

Feb 14, 2023
BUY
$197.11 - $250.07 $142,313 - $180,550
722 Added 5.14%
14,764 $3.22 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $728,118 - $999,905
3,991 Added 39.71%
14,042 $2.76 Million
Q2 2022

Aug 09, 2022
BUY
$204.13 - $302.4 $2.05 Million - $3.04 Million
10,047 Added 251175.0%
10,051 $2.15 Million
Q1 2022

May 13, 2022
BUY
$255.51 - $362.11 $511 - $724
2 Added 100.0%
4 $1,000
Q4 2021

Feb 09, 2022
SELL
$351.38 - $448.68 $9.64 Million - $12.3 Million
-27,425 Reduced 99.99%
2 $0
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $37.5 Million - $46.1 Million
-100,626 Reduced 78.58%
27,427 $11.3 Million
Q2 2021

Aug 12, 2021
SELL
$294.17 - $371.65 $959,582 - $1.21 Million
-3,262 Reduced 2.48%
128,053 $47.4 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $6.32 Million - $7.58 Million
-25,313 Reduced 16.16%
131,315 $38.1 Million
Q4 2020

Feb 11, 2021
SELL
$222.0 - $252.62 $2.39 Million - $2.72 Million
-10,757 Reduced 6.43%
156,628 $39.1 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $6.95 Million - $8.96 Million
-39,585 Reduced 19.13%
167,385 $37.9 Million
Q2 2020

Aug 13, 2020
BUY
$118.84 - $189.72 $2.49 Million - $3.97 Million
20,947 Added 11.26%
206,970 $36.1 Million
Q1 2020

May 14, 2020
BUY
$98.9 - $178.34 $563,136 - $1.02 Million
5,694 Added 3.16%
186,023 $23.5 Million
Q4 2019

Feb 13, 2020
BUY
$126.05 - $152.76 $5.58 Million - $6.77 Million
44,303 Added 32.57%
180,329 $27.5 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $11.3 Million - $13 Million
90,419 Added 198.26%
136,026 $18 Million
Q2 2019

Aug 14, 2019
BUY
$123.4 - $148.55 $185,100 - $222,825
1,500 Added 3.4%
45,607 $6.47 Million
Q1 2019

May 13, 2019
BUY
$104.82 - $146.73 $4.21 Million - $5.89 Million
40,157 Added 1016.63%
44,107 $6.41 Million
Q4 2018

Feb 13, 2019
BUY
$105.09 - $137.23 $278,068 - $363,110
2,646 Added 202.91%
3,950 $447,000
Q3 2018

Nov 13, 2018
SELL
$112.11 - $134.54 $162,111 - $194,544
-1,446 Reduced 52.58%
1,304 $175,000
Q4 2015

Jul 24, 2019
BUY
N/A
400 Added 17.02%
2,750 $221,000
Q3 2015

Jul 15, 2019
SELL
N/A
-655 Reduced 21.8%
2,350 $149,000
Q2 2015

Jul 08, 2019
BUY
N/A
3,005
3,005 $211,000

Others Institutions Holding CRL

# of Institutions
624
Shares Held
54.9M
Call Options Held
695K
Put Options Held
809K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email